መነሻ › ፎሊኩላር ሊምፎማ › Wisconsin › Milwaukee
በMilwaukee፣ WI ለፎሊኩላር ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለፎሊኩላር ሊምፎማ የሚደረጉ 19 ጥናቶች በMilwaukee እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 ማይል ርቀት
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 ማይል ርቀት
- እና 3 ተጨማሪ
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Vivent Health, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Children's Hospital of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Milwaukee
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Research Site, Milwaukee
A Study of ARC-02 in B-cell NHL
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Medical College of Wisconsin, Milwaukee
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Prohealth Care Inc, Waukesha · 17 ማይል ርቀት
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Medical College of Wisconsin, Milwaukee
Epcoritamab and Rituximab for First-line Follicular Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Medical College of Wisconsin, Milwaukee
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- The Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Milwaukee
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- CIBMTR, Milwaukee
በሌሎች ከተሞች ለፎሊኩላር ሊምፎማ የሚደረጉ ጥናቶች
- New York City, NY24 ጥናቶች
- Nashville, TN18 ጥናቶች
- Houston, TX18 ጥናቶች
- Boston, MA17 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Seattle, WA15 ጥናቶች
- Durham, NC15 ጥናቶች
- Salt Lake City, UT13 ጥናቶች
- Columbus, OH13 ጥናቶች
- Chicago, IL12 ጥናቶች
- San Antonio, TX12 ጥናቶች
- Philadelphia, PA12 ጥናቶች
በMilwaukee ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር23 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)22 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር22 ጥናቶች
- Multiple Myeloma21 ጥናቶች
- የሳንባ ካንሰር21 ጥናቶች
- የፕሮስቴት ካንሰር20 ጥናቶች
- ኖን-ሆጅኪን ሊምፎማ18 ጥናቶች
- የፓንክሪያስ ካንሰር18 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ17 ጥናቶች
- የእንቁላል ካንሰር17 ጥናቶች
- ዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ16 ጥናቶች
- በርኪት ሊምፎማ16 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።